FDA Approves New Antibiotic for Three Different Uses

FDA Approves New Antibiotic for Three Different Uses

FDA News Release FDA Approves New Antibiotic for Three Different Uses - For Immediate Release: - Today, the U.S. Food and Drug Administration approved Zevtera (ceftobiprole medocaril sodium for injection) for the treatment of adults with Staphylococcus aureus bloodstream infections (bacteremia) (SAB), including those with right-sided infective endocarditis; adults with acute bacterial skin and skin structure infections (ABSSSI); and adult and pediatric patients three months to less than 18 years old with community-acquired bacterial pneumonia (CABP). “The FDA is committed …